Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder

Acta Psychiatrica Scandinavica

Volumn 133, Issue 2, 2016, Pages 144-153

  Mcelroy, S L ^a,b   Kemp, D E ^c   Friedman, E S ^d   Reilly Harrington, N A ^e,f   Sylvia, L G ^e,f   Calabrese, J R ^c   Rabideau, D J ^e   Ketter, T A ^g   Thase, M E ^h   Singh, V ⁱ   Tohen, M ^j   Bowden, C L ⁱ   Bernstein, E E ^e   Brody, B D ^k   Deckersbach, T ^e,f   Kocsis, J H ^k   Kinrys, G ^e,f   Bobo, W V ^l   Kamali, M ^m   Mcinnis, M G ^m   Leon, A C ^k   Faraone, S ⁿ   Nierenberg, A A ^e,f   Shelton, R C ^o   more..

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LINDNER CENTER OF HOPE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ University of Texas Health Science Center   (United States)

^j UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^k WEILL CORNELL MEDICAL COLLEGE   (United States)

^l MAYO CLINIC   (United States)

^m UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

ⁿ SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^o UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

Bipolar disorder; Metabolic syndrome; Obesity; Outcome

Indexed keywords

LITHIUM; QUETIAPINE;

ABDOMINAL OBESITY; ADULT; ARTICLE; BIPOLAR DISORDER; DEPRESSION; FEMALE; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; TREATMENT OUTCOME;

EID: 84953836575     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12460     Document Type: Article

References (55)

1. McElroy SL, Keck PE Jr. Obesity in bipolar disorder: an overview. Curr Psychiatry Rep 2012;14:650-658.
2. Liu CS, Carvalho AF, Mansur RB, McIntyre RS. Obesity and bipolar disorder: synergistic neurotoxic effects? Adv Ther 2013;30:987-1006.
3. Winham SJ, Cuellar-Barboza AB, Oliveros A et al. Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2. Mol Psychiatry 2014;19:1010-1016.
4. Vancampfort D, Vansteelandt K, Correll CU et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 2013;170:265-274.
5. McElroy SL, Keck PE. Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. J Clin Psychiatry 2014;75:46-61.
6. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013;93:359-404.
7. Vannucchi G, Toni C, Maremmani I, Perugi G. Does obesity predict bipolarity in major depressive patients? J Affect Disord 2014;155:118-122.
8. Hayes JF, Miles J, Walters K, King M, Osborn DP. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand 2015;131:417-425.
9. McElroy SL, Frye MA, Suppes T et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-213.
10. Jerrell JM, McIntyre RS, Tripathi A. A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. J Clin Psychiatry 2010;71:1518-1525.
11. Goldstein BI, Liu SM, Schaffer A, Sala R, Blanco C. Obesity and the three-year longitudinal course of bipolar disorder. Bipolar Disord 2013;15:284-293.
12. Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003;160:112-117.
13. Fagiolini A, Kupfer DJ, Rucci P, Scott JA, Novick DM, Frank E. Suicide attempts and ideation in patients with bipolar I disorder. J Clin Psychiatry 2004;65:509-514.
14. Goldstein BI, Birmaher B, Axelson DA et al. Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. J Clin Psychiatry 2008;69:1953-1959.
15. Calkin C, van de Velde C, Ruzickova M et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord 2009;11:650-656.
16. Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 2010;12:404-413.
17. Goldstein BI, Liu SM, Zivkovic N, Schaffer A, Chien LC, Blanco C. The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord 2011;13:387-395.
18. Yim CY, Soczynska JK, Kennedy SH, Woldeyohannes HO, Brietzke E, McIntyre RS. The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Eur Psychiatry 2012;27:223-228.
19. McElroy SL, Crow S, Biernacka JM et al. Clinical phenotype of bipolar disorder with comorbid binge eating disorder. J Affect Disord 2013;150:981-986.
20. Kemp DE, Sylvia LG, Calabrese JR et al. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand 2014;129:24-34.
21. Vitiello B, Riddle MA, Yenokyan G et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. J Am Acad Child Adolesc Psychiatry 2012;51:867-878.
22. Miller S, Ittasakul P, Wang PW et al. Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder. J Clin Psychopharmacol 2012;32:814-819.
23. Kemp DE, Eudicone JM, McQuade RD, Chambers JS, Baker RA. Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010). J Clin Psychopharmacol 2010;30:631-634.
24. Kemp DE, Karayal ON, Calabrese JR et al. Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles. Eur Neuropsychopharmacol 2012;22:123-131.
25. Nierenberg AA, Sylvia LG, Leon AC et al. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin Trials 2014;11:114-127.
26. Nierenberg AA, McElroy SL, Friedman ES et al. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic six month trial of lithium vs. quetiapine for bipolar disorder. J Clin Psychiatry, in press.
27. Sylvia LG, Shelton RC, Kemp DE et al. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord 2015;17:212-223.
28. Suppes T, Dennehy EB, Hirschfeld RM et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005;66:870-886.
29. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):22-33; quiz 34-57.
30. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997;73:159-171.
31. Bowden CL, Singh V, Thompson P et al. Development of the Bipolar Inventory of Symptoms Scale. Acta Psychiatr Scand 2007;116:189-194.
32. Gonzalez JM, Bowden CL, Katz MM et al. Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability. Int J Methods Psychiatr Res 2008;17:198-209.
33. Leon AC, Solomon DA, Mueller TI et al. A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT. Longitudinal interval follow-up evaluation-range impaired functioning tool. J Nerv Ment Dis 2000;188:805-812.
34. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-326.
35. National Institutes of Health. National Heart, Lung and Blood Institute: clinical guidelines on the identification, evaluation and treatment of overweight in adults: the evidence report. Bethesda, MD: National Institutes of Health. 1998.
36. Jensen MD, Ryan DH, Apovian CM et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014;129(25 Suppl. 2):S102-S138.
37. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.
38. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000;11:561-570.
39. Bond DJ, Lang DJ, Noronha MM et al. The association of elevated body mass index with reduced brain volumes in first-episode mania. Biol Psychiatry 2011;70:381-387.
40. Bond DJ, Ha TH, Lang DJ et al. Body mass index-related regional gray and white matter volume reductions in first-episode mania patients. Biol Psychiatry 2014;76:138-145.
41. Kuswanto CN, Sum MY, Yang GL, Nowinski WL, McIntyre RS, Sim K. Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania. Psychol Med 2014;44:533-541.
42. Otto MW, Simon NM, Wisniewski SR et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 2006;189:20-25.
43. Shelton RC, Miller AH. Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 2010;91:275-299.
44. Shelton RC, Miller AH. Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci 2011;13:41-53.
45. Reininghaus EZ, McIntyre RS, Reininghaus B et al. Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report. Bipolar Disord 2014;16:432-440.
46. Cai D. Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab 2013;24:40-47.
47. Buckman LB, Hasty AH, Flaherty DK et al. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav Immun 2014;35:33-42.
48. Jeong SK, Nam HS, Son MH, Son EJ, Cho KH. Interactive effect of obesity indexes on cognition. Dement Geriatr Cogn Disord 2005;19:91-96.
49. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005;330:1360.
50. Verstynen TD, Weinstein AM, Schneider WW, Jakicic JM, Rofey DL, Erickson KI. Increased body mass index is associated with a global and distributed decrease in white matter microstructural integrity. Psychosom Med 2012;74:682-690.
51. Coplan JD, Fathy HM, Abdallah CG et al. Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight. Neuroimage Clin 2014;4:326-335.
52. Yokum S, Ng J, Stice E. Relation of regional gray and white matter volumes to current BMI and future increases in BMI: a prospective MRI study. Int J Obes (Lond) 2012;36:656-664.
53. Kivimaki M, Shipley MJ, Batty GD et al. Long-term inflammation increases risk of common mental disorder: a cohort study. Mol Psychiatry 2014;19:149-150.
54. Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008;32(Suppl. 3):S56-S59.
55. Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One 2012;7:e33308.